Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
PI3K inhibitor |
| gptkbp:CASNumber |
154447-36-6
|
| gptkbp:developedBy |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:hasApplication |
cancer research
cell signaling studies |
| gptkbp:hasInChIKey |
RNUZLZULXHKNPK-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C19H17NO3
|
| gptkbp:hasSMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C=CC=C3C4=CC=CC=C4
|
| https://www.w3.org/2000/01/rdf-schema#label |
LY 294002
|
| gptkbp:inhibitedBy |
phosphoinositide 3-kinases
|
| gptkbp:is_not_approved_for_clinical_use |
true
|
| gptkbp:IUPACName |
gptkb:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
|
| gptkbp:mechanismOfAction |
ATP-competitive inhibitor of PI3K
|
| gptkbp:meltingPoint |
204-206 °C
|
| gptkbp:molecularWeight |
307.34 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL958
3973 3836 |
| gptkbp:synonym |
gptkb:LY294002
2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
| gptkbp:used_in |
biochemical research
|
| gptkbp:bfsParent |
gptkb:PI3K_inhibitor_LY294002
|
| gptkbp:bfsLayer |
6
|